Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02657317
Recruitment Status : Recruiting
First Posted : January 15, 2016
Last Update Posted : September 24, 2018
Sponsor:
Collaborator:
South Texas Veterans Health Care System
Information provided by (Responsible Party):
The University of Texas Health Science Center at San Antonio

Brief Summary:
This is a research study of an interdisciplinary pain management program for U.S. military veterans who served during the post-9/11 combat eras (e.g., Operations Iraqi Freedom [OIF], Enduring Freedom [OEF], New Dawn [OND]) presenting with chronic musculoskeletal pain related to military service with comorbid depression and/or posttraumatic stress disorder [PTSD] symptoms and/or mild traumatic brain injury. This study will test the efficacy of an interdisciplinary pain program compared to treatment as usual in the Veterans Health Administration on pain-related disability, opioid medication use, and pain coping.

Condition or disease Intervention/treatment Phase
Chronic Pain Traumatic Brain Injury Posttraumatic Stress Disorder Depression Opioid Use Disorder Behavioral: FORT-A Other: VA Treatment as Usual Not Applicable

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 130 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in a Combat-Injured Veterans Population
Study Start Date : January 2016
Estimated Primary Completion Date : August 2019
Estimated Study Completion Date : August 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: FORT-A
has been labeled "FORT-A." FORT-A is provided on an outpatient basis and includes 12 daily group pain management and physical therapy sessions spanning three weeks. Group interventions are supplemented by individual psychotherapy, biofeedback, and case staffings. CBT sessions were decreased in favor of CAM components. FORT-A participants will receive 270 minutes (4½ hours) of intervention a day for 12 days over 3 weeks.
Behavioral: FORT-A
FORT-A is based on a functional restoration paradigm of pain management in which treatment is interdisciplinary and designed to achieve a functional goal (often specified by the patient; e.g., doing more with family, returning to work). FORT-A includes intensive functional rehabilitation, group-based pain management intervention, and individual interventions tailored to the patient's specific needs (e.g., biofeedback for stress, individual psychotherapy for mood or trauma symptoms).
Other Name: Functional Restoration for Pain

Active Comparator: VA Treatment As Usual
Treatment As Usual (TAU) represents usual VA Care based on "as usual" appointments and referrals from VA providers. TAU can include active medical interventions, psychosocial intervention, and other rehabilitation strategies.
Other: VA Treatment as Usual
VA TAU includes referrals for specialty intervention, rehabilitation, and behavioral health intervention within the VA medical system. Some participants may be referred for care outside of the VA system. The South Texas Veterans Health Care System offers a wide range of pain management services.
Other Name: TAU




Primary Outcome Measures :
  1. Change in Oswestry Disability Index [ Time Frame: Pre-Treatment, Post-Treatment 3 weeks after Pre-Treatment, Follow-Up 6 Months After Post-Treatment, Follow-Up 12 Months After Post-Treatment ]
    self-report disability measure


Secondary Outcome Measures :
  1. Change in Lifting Capacity [ Time Frame: Pre-Treatment, Post-Treatment 3 weeks after Pre-Treatment, Follow-Up 6 Months After Post-Treatment, Follow-Up 12 Months After Post-Treatment ]
    amount lifted in pounds from floor-to-waist level and from waist-to-eye level

  2. Change in Aerobic Capacity [ Time Frame: Pre-Treatment, Post-Treatment 3 weeks after Pre-Treatment, Follow-Up 6 Months After Post-Treatment, Follow-Up 12 Months After Post-Treatment ]
    oxygen used during walking task (%VO2)

  3. Change in Gait [ Time Frame: Pre-Treatment, Post-Treatment 3 weeks after Pre-Treatment, Follow-Up 6 Months After Post-Treatment, Follow-Up 12 Months After Post-Treatment ]
    distance walked (in meters) over time (in minutes/seconds)

  4. Change in Range of Motion [ Time Frame: Pre-Treatment, Post-Treatment 3 weeks after Pre-Treatment, Follow-Up 6 Months After Post-Treatment, Follow-Up 12 Months After Post-Treatment ]
    degrees of motion a body part is able to move

  5. Timeline Followback Interview for Opioid Medication Use (dose frequency) [ Time Frame: Pre-Treatment, Post-Treatment 3 weeks after Pre-Treatment, every month for 12 months after post-treatment ]
    monthly interview about opioid medication use in the past month (frequency of dose - times used per day)

  6. Timeline Followback Interview for Opioid Medication Use (# pills) [ Time Frame: Pre-Treatment, Post-Treatment 3 weeks after Pre-Treatment, every month for 12 months after post-treatment ]
    monthly interview about opioid medication use in the past month (number of pills used per day)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 72 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Demographics for inclusion in this research include both genders, all racial/ethnic groups, and ages 18-72.
  2. Present with chronic musculoskeletal pain (CMP) as a primary pain complaint
  3. CMP is accompanied by at least moderate disability based on a score of 20% or more on the Oswestry Disability Index;
  4. Consistent with NIH Task Force recommendations, "chronic" CMP has been a problem for the Veteran for at least half the days in the last 3 months and was acquired or exacerbated as part of active duty U.S. military service in the Operations Iraqi Freedom (OIF), Enduring Freedom (OEF), or New Dawn (OND) war eras.
  5. CMP presents in the context of comorbid psychiatric symptoms of posttraumatic stress disorder (PTSD; based on a score of 25 or more on the PTSD Checklist-Version 5) and/or depression (based on a score of 10 or more on the Beck Depression Inventory-2).
  6. Demonstrate prior "chronic" opioid use (defined as using opioid medication for 20 out of every 30 days over three or more months) and discharged off of persistent opioid medications by a VA provider since the onset of the VA Opioid Safety Initiative (2013).
  7. Speak and read/understand English well enough to fully participate in the intervention and to reliably complete assessment measures.
  8. The Veteran will be eligible to be a PRC patient (i.e., have multiple trauma related physical and psychological injuries; VA, 2013) and be eligible for Physical Therapy referral through the PRC (though the referral for the same service could also come from another VHA provider). All participants will be offered Physical Therapy services before enrollment and will be enrolled after completing or denying Physical Therapy.

Exclusion Criteria:

  1. Actively engaged in an intervention or program specifically targeting opioid use (including those using naloxone).
  2. Present with active psychosis or suicidal ideation with intent. These symptoms must be stabilized (i.e., maintained at or below moderate intensity for 6 weeks with no acute episodes requiring higher levels of intervention) through a VHA Psychology or Psychiatry referral and confirmed by the mental health provider before the Veteran is eligible to participate.
  3. CMP is not related to or exacerbated by military service during the OEF/OIF/OND combat eras.
  4. Present with significantly diminished decision-making capacity (e.g., severe cognitive dysfunction related to severe TBI).
  5. Pregnant women
  6. Inability or unwillingness of individual or legal guardian/representative to give written informed consent.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02657317


Contacts
Layout table for location contacts
Contact: Donald D McGeary, PhD 210-562-6708 mcgeary@uthscsa.edu
Contact: Cindy A McGeary, PhD 210-562-6721 mcgearyc@uthscsa.edu

Locations
Layout table for location information
United States, Texas
South Texas Veterans Health Care System Recruiting
San Antonio, Texas, United States, 78228
Contact: Donald D McGeary, PhD    210-562-6708    mcgeary@uthscsa.edu   
Sponsors and Collaborators
The University of Texas Health Science Center at San Antonio
South Texas Veterans Health Care System
Investigators
Layout table for investigator information
Principal Investigator: Donald D McGeary, PhD University of Texas Health Science Center San Antonio
Principal Investigator: Blessen Eapen, MD South Texas Veterans Health Care System
Principal Investigator: Cindy A McGeary, PhD University of Texas Health Science Center San Antonio
Principal Investigator: Carlos Jaramillo, MD, PhD South Texas Veterans Health Care System

Layout table for additonal information
Responsible Party: The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier: NCT02657317     History of Changes
Other Study ID Numbers: R01AT008422-01 ( U.S. NIH Grant/Contract )
HSC20140396 ( Other Identifier: UTHSCSA )
First Posted: January 15, 2016    Key Record Dates
Last Update Posted: September 24, 2018
Last Verified: September 2018

Keywords provided by The University of Texas Health Science Center at San Antonio:
chronic pain
pain management
trauma
ptsd
tbi
opioid medication

Additional relevant MeSH terms:
Layout table for MeSH terms
Brain Injuries
Brain Injuries, Traumatic
Stress Disorders, Post-Traumatic
Brain Diseases
Craniocerebral Trauma
Trauma, Nervous System
Wounds and Injuries
Stress Disorders, Traumatic
Trauma and Stressor Related Disorders
Disease
Chronic Pain
Pathologic Processes
Central Nervous System Diseases
Nervous System Diseases
Pain
Neurologic Manifestations
Signs and Symptoms
Mental Disorders